Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure

[1]  B. Cosío,et al.  Chronic Obstructive Pulmonary Disease in Non-Smokers. , 2017, Archivos de bronconeumologia.

[2]  Eda Dou,et al.  Integrating smoking cessation into lung cancer screening programs. , 2016, Clinical imaging.

[3]  O. Arrieta,et al.  Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox". , 2015, Lung cancer.

[4]  U. Kleeberg,et al.  Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter. , 2015, The oncologist.

[5]  Matthew Meyerson,et al.  Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Yiting Tang,et al.  Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo , 2015, Scientific Reports.

[7]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[8]  C. Belani,et al.  Afatinib for the treatment of metastatic non-small cell lung cancer , 2015, Cancer management and research.

[9]  A. Cardona,et al.  KRAS Mutation as the Biomarker of Response to Chemotherapy and EGFR-TKIs in Patients With Advanced Non–Small Cell Lung Cancer: Clues For Its Potential Use in Second-Line Therapy Decision Making , 2015, American journal of clinical oncology.

[10]  R. Rosell,et al.  The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer. , 2015, Lung cancer.

[11]  M. Brock,et al.  Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[12]  K. Luettich,et al.  Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[13]  R. Salgia,et al.  MET as a possible target for non-small-cell lung cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Perez-Padilla,et al.  [National consensus of diagnosis and treatment of non-small cell lung cancer]. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[15]  Honggang Wang,et al.  Cigarette Smoke Condensate Induces Differential Expression and Promoter Methylation Profiles of Critical Genes Involved in Lung Cancer in NL-20 Lung Cells In Vitro , 2013, International journal of toxicology.

[16]  A. Cardona,et al.  Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non–Small-Cell Lung Cancer Related to Wood-Smoke Exposure , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  Yuh-Min Chen,et al.  Association between Tumor Epidermal Growth Factor Receptor Mutation and Pulmonary Tuberculosis in Patients with Adenocarcinoma of the Lungs , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  H. Li,et al.  Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. , 2011, Advances in medical sciences.

[19]  R. Rosell,et al.  Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  T. Mitsudomi,et al.  Lung cancer in never smokers: change of a mindset in the molecular era. , 2011, Lung cancer.

[21]  L. Mølhave,et al.  Oxidative stress, DNA damage, and inflammation induced by ambient air and wood smoke particulate matter in human A549 and THP-1 cell lines. , 2011, Chemical research in toxicology.

[22]  C. Van Waes,et al.  EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy , 2011, Expert opinion on therapeutic targets.

[23]  Wei-Chih Liao,et al.  Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[25]  Akshay Sood,et al.  Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. , 2010, American journal of respiratory and critical care medicine.

[26]  Rafael A. Irizarry,et al.  A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..

[27]  B. Vanhaesebroeck,et al.  The emerging mechanisms of isoform-specific PI3K signalling , 2010, Nature Reviews Molecular Cell Biology.

[28]  A. Sasco,et al.  High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer , 2010, British Journal of Cancer.

[29]  S. Salvi,et al.  Chronic obstructive pulmonary disease in non-smokers , 2009, The Lancet.

[30]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[31]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[32]  W. Lam,et al.  PIK3CA mutations and copy number gains in human lung cancers. , 2008, Cancer research.

[33]  O. Arrieta,et al.  Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients: An Open Label Phase II Study , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[34]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[35]  Gaetano Rocco,et al.  Activating E17K mutation in the gene encoding the protein kinase AKT in a subset of squamous cell carcinoma of the lung , 2008, Cell cycle.

[36]  J. Engelman,et al.  Acquired resistance to tyrosine kinase inhibitors during cancer therapy. , 2008, Current opinion in genetics & development.

[37]  A. Letai,et al.  Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion. , 2007, Cancer research.

[38]  W. Pao,et al.  Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas , 2007, PLoS medicine.

[39]  A. Gazdar,et al.  Lung cancer in never smokers — a different disease , 2007, Nature Reviews Cancer.

[40]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[41]  M. Brauer,et al.  Woodsmoke Health Effects: A Review , 2007, Inhalation toxicology.

[42]  Daniela Hoeller,et al.  Ubiquitin and ubiquitin-like proteins in cancer pathogenesis , 2006, Nature Reviews Cancer.

[43]  Renato Martins,et al.  Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.

[44]  G. González-Ávila,et al.  Lung cancer pathogenesis associated with wood smoke exposure. , 2005, Chest.

[45]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[46]  M. Pacyna‐Gengelbach,et al.  Characterization of γ-Aminobutyric Acid Type A Receptor–Associated Protein, a Novel Tumor Suppressor, Showing Reduced Expression in Breast Cancer , 2005, Cancer Research.

[47]  M. Mori,et al.  GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Prakash Chinnaiyan,et al.  Dual-Agent Molecular Targeting of the Epidermal Growth Factor Receptor (EGFR) , 2004, Cancer Research.

[49]  M Brauer,et al.  Wood smoke exposure and lung adenocarcinoma in non-smoking Mexican women. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[50]  R. Sansores,et al.  Matrix metalloproteinases activity in COPD associated with wood smoke. , 2004, Chest.

[51]  M. Jouvenot,et al.  Expression of gec1/GABARAPL1 versus GABARAP mRNAs in human: predominance of gec1/GABARAPL1 in the central nervous system. , 2003, Brain research. Molecular brain research.

[52]  J. Baselga,et al.  Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Lesley Seymour,et al.  Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. , 2003, The Lancet. Oncology.

[54]  G. Giaccone,et al.  Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[56]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[57]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[58]  Roy S Herbst,et al.  Monoclonal antibodies to target epidermal growth factor receptor–positive tumors , 2002, Cancer.

[59]  J. Zelikoff,et al.  THE TOXICOLOGY OF INHALED WOODSMOKE , 2002, Journal of toxicology and environmental health. Part B, Critical reviews.

[60]  D Behera,et al.  Respiratory symptoms in Indian women using domestic cooking fuels. , 1991, Chest.

[61]  J. Watt.  International Association for the Study of Lung Cancer (IASLC) - 18th World Conference on Lung Cancer (WCLC 2017). Yokohama, Japan - October 15-18, 2017 , 2017 .

[62]  A. Nicholson,et al.  49 Increasing incidence of non-smoking lung cancer: presentation of patients with early disease to a tertiary institution in the UK , 2016 .

[63]  K. Varming,et al.  Exosomes and Their Potential for Detection of Lung Cancer , 2015 .

[64]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[65]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[66]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[67]  M. Pacyna‐Gengelbach,et al.  Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer. , 2005, Cancer research.

[68]  B. Storer,et al.  Competing Interests: The authors , 2004 .

[69]  G. Giaccone,et al.  The epidermal growth factor receptor pathway and its inhibition as anticancer therapy. , 2003, Drugs of today.

[70]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[71]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[72]  John D. Storey,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .